Rifamycin SV-MMX® Tablets Versus Ciprofloxacin Capsules in Acute Traveller's Diarrhoea

Clinical trial NCT01208922 · COMPLETED

Trial details

NCT number: NCT01208922
Sponsor: Dr. Falk Pharma GmbH
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Traveler's Diarrhea

Start date: 2010-11-01
Primary completion: 2016-01-01
Enrollment: 835

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.